Alterra Labs Raises $12.5M Seed Round

New York startup Alterra Labs, which builds simulated clinical settings to test AI models, closed a $12.5 million seed round led by Oak HC/FT.

Updated on Nov. 10, 2026 in Healthcare

Isometric editorial illustration of an empty simulated clinical exam bay with a mannequin torso on a table beside a window overlooking a city block.
Alterra Labs, a New York startup, raised a $12.5 million seed round led by Oak HC/FT to build simulated clinical settings for testing AI models on medical tasks. AI Illustration. Upload story photo >

Alterra Labs, a New York startup, closed a $12.5 million seed round led by Oak HC/FT, with Flare Capital Partners and Company Ventures also participating. The company builds simulated clinical settings where AI models are run through medical tasks.

Why it matters

The funding supports a platform in which doctors and scientists evaluate model decisions, with their judgments fed back to developers. The company's work with health systems, pharmaceutical companies, biotech firms, and government entities places it at the intersection of AI development and healthcare oversight.

Alterra Labs closed a $12.5 million seed round, the sole quantitative figure disclosed in the announcement. The extraction provides no comparator, valuation, or revenue data, so the round's relative size within healthcare AI funding cannot be assessed from the available facts.

The players

Alterra Labs

A New York startup that builds simulated clinical settings for evaluating AI models in medical tasks.

Oak HC/FT

The venture firm that led Alterra Labs' $12.5 million seed round.

Responsible AI Institute

The organization whose TrustX Health working group Alterra Labs joined.

The details

Alterra Labs builds simulated clinical settings in which AI models are run through medical tasks, with doctors and scientists helping design those tasks and evaluate the models' decisions. The company also joined the Responsible AI Institute's TrustX Health working group.

Timeline

  1. November 10, 2026: Seed round announcement published.

Market Landscape

Alterra Labs' membership in the Responsible AI Institute's TrustX Health working group places its simulated clinical evaluation platform within a growing set of efforts to standardize trust in healthcare AI. The company's work with health systems, pharmaceutical companies, and government entities situates it among firms seeking validation mechanisms before clinical deployment.

For healthcare providers and institutions, Alterra Labs' platform could become a channel for evaluating AI tools before they are used with patients. Readers working in clinical or administrative roles may see such pre-deployment testing shape which AI products reach their organizations.

The takeaway

Independent clinical-style evaluation of AI models, with physician feedback built in, is emerging as a funded category in its own right. Stakeholders assessing healthcare AI tools may find that asking how a model was tested in simulated medical tasks offers useful insight into its reliability.

Further reading

Explore more Healthcare coverage for context on AI evaluation and medical technology funding.